Sensitization of neurons in the central nucleus of the amygdala via the decreased GABAergic inhibition contributes to the development of neuropathic pain-related anxiety-like behaviors in rats

Molecular Brain

Volumn 7, Issue 1, 2014, Pages

  Jiang, Hong ^a   Fang, Dong ^a   Kong, Ling Yu ^a   Jin, Zi Run ^a   Cai, Jie ^a   Kang, Xue Jing ^a   Wan, You ^b,c   Xing, Guo Gang ^a,b,c  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BICUCULLINE METHIODIDE; DIAZEPAM; MUSCIMOL; 4 AMINOBUTYRIC ACID RECEPTOR; BICUCULLINE; CASPASE 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN NERVE CELL; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; GABAERGIC TRANSMISSION; MALE; NERVE CELL; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL PLASTICITY; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SPINAL NERVE; ACTION POTENTIAL; ANIMAL; ANIMAL BEHAVIOR; APOPTOSIS; CELL MEMBRANE; COMPLICATION; DRUG EFFECTS; HYPERALGESIA; LIGATION; METABOLISM; NERVE CELL INHIBITION; NEURALGIA; PATHOLOGY; SPRAGUE DAWLEY RAT; TUNEL ASSAY; WESTERN BLOTTING;

ACTION POTENTIALS; ANIMALS; ANXIETY; APOPTOSIS; BEHAVIOR, ANIMAL; BICUCULLINE; BLOTTING, WESTERN; CASPASE 3; CELL MEMBRANE; CENTRAL AMYGDALOID NUCLEUS; GABAERGIC NEURONS; HYPERALGESIA; IN SITU NICK-END LABELING; LIGATION; MALE; MUSCIMOL; NEURAL INHIBITION; NEURALGIA; RATS, SPRAGUE-DAWLEY; SPINAL NERVES;

EID: 84964697618     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/s13041-014-0072-z     Document Type: Article

References (50)

1. Simons LE, Elman I, Borsook D: Psychological processing in chronic pain: A neural systems approach. Neurosci Biobehav Rev 2014, 39:61-78.
2. Knaster P, Karlsson H, Estlander AM, Kalso E: Psychiatric disorders as assessed with SCID in chronic pain patients: The anxiety disorders precede the onset of pain. Gen Hosp Psychiatry 2012, 34:46-52.
3. McCracken LM, Keogh E: Acceptance, mindfulness, and values-based action may counteract fear and avoidance of emotions in chronic pain: An analysis of anxiety sensitivity. J Pain 2009, 10:408-415.
4. Neugebauer V, Galhardo V, Maione S, Mackey SC: Forebrain pain mechanisms. Brain Res Rev 2009, 60:226-242.
5. Liu MG, Chen J: Preclinical research on pain comorbidity with affective disorders and cognitive deficits: Challenges and perspectives. Prog Neurobiol 2014, 116:13-32.
6. Neugebauer V, Li W, Bird GC, Han JS: The amygdala and persistent pain. Neuroscientist 2004, 10:221-234.
7. Krettek JE, Price JL: A description of the amygdaloid complex in the rat and cat with observations on intra-Amygdaloid axonal connections. J Comp Neurol 1978, 178:255-280.
8. McDonald AJ: Cytoarchitecture of the central amygdaloid nucleus of the rat. J Comp Neurol 1982, 208:401-418.
9. Akmaev IG, Kalimullina LB, Sharipova LA: The central nucleus of the amygdaloid body of the brain: cytoarchitectonics, neuronal organization, connections. Neurosci Behav Physiol 2004, 34:603-610.
10. Roozendaal B, McEwen BS, Chattarji S: Stress, memory and the amygdala. Nat Rev Neurosci 2009, 10:423-433.
11. Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, Luthi A: Amygdala inhibitory circuits and the control of fear memory. Neuron 2009, 62:757-771.
12. Duvarci S, Pare D: Amygdala microcircuits controlling learned fear. Neuron 2014, 82:966-980.
13. Neugebauer V, Li W: Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain. J Neurophysiol 2003, 89:716-727.
14. Neugebauer V, Li W, Bird GC, Bhave G, Gereau RW: Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5. J Neurosci 2003, 23:52-63.
15. Casarrubea M, Sorbera F, Santangelo A, Crescimanno G: The effects of diazepam on the behavioral structure of the rat's response to pain in the hot-plate test: Anxiolysis vs. pain modulation. Neuro pharmacology 2012, 63:310-321.
16. LeDoux JE, Iwata J, Cicchetti P, Reis DJ: Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988, 8:2517-2529.
17. LeDoux JE: Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
18. Heath NC, Rizwan AP, Engbers JD, Anderson D, Zamponi GW, Turner RW: The expression pattern of a Cav3-Kv4 complex differentially regulates spike output in cerebellar granule cells. J Neurosci 2014, 34:8800-8812.
19. Nieus TR, Mapelli L, D'Angelo E: Regulation of output spike patterns by phasic inhibition in cerebellar granule cells. Front Cell Neurosci 2014, 8:246.
20. Remy S, Csicsvari, Beck H: Activity-dependent control of neuronal output by local and global dendritic spike attenuation. Neuron 2009, 61:906-916.
21. Knobloch HS, Charlet A, Hoffmann LC, Eliava M, Khrulev S, Cetin AH: Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
22. Li H, Penzo MA H, Taniguchi, Kopec CD, Huang T: Experience-dependent modification of a central amygdala fear circuit. Nat Neurosci 2013, 16:332-339.
23. Ueyama T: Emotion, amygdala, and autonomic nervous system. Brain Nerve 2012, 64:1113-1119.
24. Ledri M, Madsen MG, Nikitidou, Kirik D, Kokaia M: Global optogenetic activation of inhibitory interneurons during epileptiform activity. J Neurosci 2014, 34:3364-3377.
25. Lee V, Maguire J: The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type. Front Neural Circuits 2014, 8:3.
26. Bartos M, Vida I, Jonas P: Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 2007, 8:45-56.
27. Quirk GJ, Gehlert DR: Inhibition of the amygdala: key to pathological states? Ann N Y Acad Sci 2003, 985:263-272.
28. Makkar SR, Zhang SQ, Cranney J: Behavioral and neural analysis of GABA in the acquisition, consolidation, reconsolidation, and extinction of fear memory. Neuropsychopharmacology 2010, 35:1625-1652.
29. Altamura AC, Moliterno D, Paletta S, Maffini M, Mauri MC, Bareggi S: Understanding the pharmacokinetics of anxiolytic drugs. Expert Opin Drug Metab Toxicol 2013, 9:423-440.
30. Cain SM, Snutch TP: T-Type calcium channels in burst-firing, network synchrony, and epilepsy. Biochim Biophys Acta 1828, 2013:1572-1578.
31. Azouz R, Jensen MS, Yaari Y: Ionic basis of spike after-depolarization and burst generation in adult rat hippocampal CA1 pyramidal cells. J Physiol 1996, 492:211-223.
32. Mayer ML: A calcium-Activated chloride current generates the afterdepolarization of rat sensory neurones in culture. J Physiol 1985, 364:217-239.
33. Yang RH, Wang WT, Hou XH, Hu SJ, Chen JY: Ionic mechanisms of the effects of sleep deprivation on excitability in hippocampal pyramidal neurons. Brain Res 2010, 1343:135-142.
34. Johnston J, Postlethwaite M, Forsythe ID: The impact of synaptic conductance on action potential waveform: Evoking realistic action potentials with a simulated synaptic conductance. J Neurosci Methods 2009, 183:158-164.
35. Roeska K, Doods H, Arndt K, Treede RD, Ceci A: Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin. Pain 2008, 139:349-357.
36. Pedersen LH, Scheel-Kruger J, Blackburn-Munro G: Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affectivemotivational pain responses in a rat model of peripheral nerve injury. Pain 2007, 127:17-26.
37. Cunha JM, Masur J: Evaluation of psychotropic drugs with a modified open field test. Pharmacology 1978, 16:259-267.
38. Holland HC, Weldon E: A note on a new technique of recording ambulation in the open field test and its validation. Acta Psychol (Amst) 1968, 28:293-300.
39. Lister RG: The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 1987, 92:180-185.
40. Pellow S, Chopin P, File SE, Briley M: Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
41. Gholami M, Saboory E, Khalkhali HR: Chronic morphine and tramadol re-exposure induced anti-Anxiety effect in prepubertal rats neonatally exposed to the same drugs. Clin Exp Pharmacol Physiol 2014, 10:1440-1681.
42. Haydari S, Miladi-Gorji H, Mokhtari A, Safari M: Effects of voluntary exercise on anxiety-like behavior and voluntary morphine consumption in rat pups borne from morphine-dependent mothers during pregnancy. Neurosci Lett 2014, 578:50-54.
43. Parent AJ, Beaudet N, Beaudry H, Bergeron J, Berube P, Drolet G: Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behav Brain Res 2012, 229:160-167.
44. Weisberg JN, Boatwright BA: Mood, anxiety and personality traits and states in chronic pain. Pain 2007, 133:1-2.
45. Hummel M, Lu P, Cummons TAG, Whiteside GT: The persistence of a longterm negative affective state following the induction of either acute or chronic pain. Pain 2008, 140:436-445.
46. Minami M: Neuronal mechanisms underlying pain-induced negative emotions. Brain Nerve 2012, 64:1241-1247.
47. Goncalves L, Dickenson AH: Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropath pregabalin modulation. Eur J Neurosci 2012, 36:3204-3213.
48. Ji G, Fu Y, Ruppert KA, Neugebauer V: Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain 2007, 3:13-17.
49. Han JS, Neugebauer V: Synaptic plasticity in the amygdala in a visceral pain model in rats. Neurosci Lett 2004, 361:254-257.
50. Coleman-Mesches K, Salinas JAF, McGaugh JL: Unilateral amygdala inactivation after training attenuates memory for reduced reward. Behav Brain Res 1996, 77:175-180.